Technology plays a critical role in helping patients, and the clinicians and institutions they trust, make every moment matter in the fight against cancer.

With this blog, we aim to explore the challenges faced by the clinical trial and cancer registry communities and bring light to the innovative solutions that are transforming the landscape.

Most cancer centers are still not making full use of the value hidden within their cancer registry data. From better patient care...

Cancer centers have known for many years that clinical trial recruitment is a serious problem. But in recent years, a new...

Cancer centers are “overrun at all levels,” according to recent reports, with “burn-out” seen at all areas within oncology...

Efficient patient enrollment in clinical trials is essential to advancing medical research and improving cancer treatment...

Cancer registry data is like solar energy: it has been used in a form for a long time, but only with recent technological...

Oncology leaders will be hearing the term “Oncology Data Specialist” a lot in the coming years. But what does it mean – and how...

In the landscape of modern healthcare, the seamless flow of accurate and comprehensive information is not just a convenience but...

In recent years, various sectors of the healthcare industry have seen a significant increase in the use of Artificial...

Responsible AI is far more than just a talking point. It's a core component of how forward-thinking companies like Inspirata are...

Every year on September 24^th, the healthcare and research communities come together to acknowledge World Cancer Research Day....

At Inspirata, we believe that innovation is a never-ending journey. We're committed to the ongoing process of identifying,...

It’s no secret that there has been a growing awareness of the importance of diversity, equity, and inclusion (DE&I) in clinical...

Clinical trial participants hail from all walks of life. They are young and old, representing myriad races and ethnicities, and...

At Inspirata, we continuously strive to understand and address the unique needs of the cancer registry community. To gain insight...

Achieving accrual targets for oncology clinical trials has always been a significant challenge, but more recently, it seems to be...

What can you do in a second or two of time? Most of us do not give it much thought, but in the right context, you may be...

At Inspirata, we believe that using technology such as Artificial Intelligence (AI) and Natural Language Processing (NLP) to...

In a prior post, I endeavoured to introduce the importance of patient and public involvement (PPI) in the delivery of cancer...

The instant my haematologist mentioned the word cancer, I stopped listening. Not purposely of course, I was in shock. Rather than...

This week, April 5th – 9th, 2021, marks the 25th annual National Cancer Registrars Week (NCRW). This year’s theme, “Cancer...

At the end of 2020, I was delighted to take up the opportunity to join Inspirata as its business unit lead for cancer...

The astonishing success of artificial intelligence (AI) over the past few years in solving complex recognition problems has...

During a recent virtual fireside chat, I met with industry experts Courtney Hudson, President and Founder of Carebox; and Cyntha...

Back in May 2020, at the early stage of the COVID-19 pandemic, the Inspirata team was very much focused on supporting the...